Skip to main content
SIU Annual Conference Main banner
 
Presentation Icons
Surgery Day
Surgery Day
Bench-to-Bedside
Bench-to-Bedside
SIU@U
SIU@U
    Session Type: Sponsored Symposium

    Luncheon Symposium: Advancing NMIBC Management: From Clinical Evidence to Daily Practice

    Saturday, November 1, 2025
    12:45 - 14:00 GMT+0

    SIU@U

      Co-Chair(s)

    • Jeremy Teoh

      Associate Professor
      The Chinese University of Hong Kong, Hong Kong

    Learning Objectives :

    At the end of this session, attendees should be able to:
    • Identify current challenges and unmet needs in the management of NMIBC, particularly in patient selection, treatment sequencing, and integration of novel therapies.
    • Apply risk stratification to NMIBC management, with a focus on intermediate-risk subgroups and disease state based on prior BCG exposure.
    • Examine the clinical evidence supporting emerging intravesical therapies for BCG-unresponsive NMIBC.
    • Recognize strategies for NMIBC management based on risk stratification and the complexities of incorporating novel therapies into daily clinical practice.

    Presentations:

    • 12:45 - 12:50 GMT+0
      Welcome and Session Introductions

      Co-Chair: Jeremy Teoh – The Chinese University of Hong Kong

    • 12:50 - 13:05 GMT+0
      Unmet Needs in NMIBC: Clinical and Practical Considerations

      Speaker: Paolo Gontero – University of Turin

    • 13:05 - 13:15 GMT+0
      Risk Stratification and NMIBC Disease States
    • 13:15 - 13:30 GMT+0
      Novel Intravesical Therapies for BCG-Unresponsive NMIBC
    • 13:30 - 13:50 GMT+0
      Case-Based Panel Discussion

      Moderator: Jeremy Teoh – The Chinese University of Hong Kong

      Panelist: Paolo Gontero – University of Turin

    • 13:50 - 14:00 GMT+0
      Summary and Q&A